| 12139549 |
Material and methods for treating or preventing HER-3 associated diseases |
Thore Hettmann, Daniel J. Freeman |
2024-11-12 |
| 11155876 |
K-ras mutations and anti-EGFr antibody therapy |
Daniel J. Freeman, Todd Juan |
2021-10-26 |
| 10030270 |
K-ras mutations and anti-EGFr antibody therapy |
Daniel J. Freeman, Todd Juan |
2018-07-24 |
| 9988462 |
Material and methods for treating or preventing HER-3 associated diseases |
Thore Hettmann, Daniel J. Freeman, Mike Rothe |
2018-06-05 |
| 9803025 |
Material and methods for treating or preventing HER-3 associated diseases |
Thore Hettmann, Daniel J. Freeman |
2017-10-31 |
| 9101760 |
Material and methods for treating or preventing HER-3 associated diseases |
Thore Hettmann, Daniel J. Freeman |
2015-08-11 |
| 9097729 |
Methods of selecting epidermal growth factor receptor (EGFr) binding agents |
Daniel J. Freeman, Jilin Sun, Kenneth Jung, Gary Elliott |
2015-08-04 |
| 8771695 |
Antibodies directed to HER-3 and uses thereof |
Mike Rothe, Martin Treder, Susanne Hartmann, Daniel J. Freeman, Eric Borges |
2014-07-08 |
| 8546107 |
Epidermal growth factor receptor mutations |
Daniel J. Freeman, Todd Juan |
2013-10-01 |
| 7985559 |
Methods of selecting epidermal growth factor receptor (EGFR) binding agents |
Daniel J. Freeman, Jilin Sun, Kenneth Jung, Gary Elliott |
2011-07-26 |
| 7981605 |
Epidermal growth factor receptor mutations |
Daniel J. Freeman, Todd Juan |
2011-07-19 |